clinical trials for glp 1 GLP1 agonists: current and future landscape of patients with metabolic dysfunction Clinical trials suggest GLP-1s may

Uric acid urolithiasis (uric acid kidney stones) accounts for approximately 10% of all urinary calculi (stones) in the US

Side Effects Gastrointestinal symptoms: Most common adverse effects were mild-to-moderate nausea, vomiting, and diarrhea, occurring primarily during dose escalation [6] [12]

doi: 10.1080/00325481.2020.1798099 24 BlondeLUmpierrezGEReddySSMcGillJBBergaSLBushMet al

It was originally developed by Novo Nordisk and has been the subject of multiple Phase I and Phase II clinical trials, making it one of the better-characterised GHS peptides in terms of safety and pharmacokinetic data

The active ingredients in each form share similar molecular structures but differ in stability and formulation